Funding for this research was provided by:
National Institutes of Health (AI 15614)
The Interleukin Foundation
Received: 3 April 2018
Accepted: 9 July 2018
First Online: 3 August 2018
: The animal protocols of this study were approved by the University of Colorado Animal Care and Use Committee.
: Not applicable.
: CAD serves as chair of Olatec’s Scientific Advisory Board, is co-chief scientific officer, and receives compensation from Olatec. LABJ serves on Olatec’s Scientific Advisory Board and receives compensation from Olatec. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.